openPR Logo
Press release

Aneurysmal Subarachnoid Hemorrhage Drugs Market to Witness Robust Expansion by 2029

01-28-2023 07:26 AM CET | Health & Medicine

Press release from: Orion Market Research

Aneurysmal Subarachnoid Hemorrhage Drugs Market to Witness

Aneurysmal subarachnoid hemorrhage drugs market is anticipated to grow at a significant CAGR during the forecast period. Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke. It is caused by bleeding in the space surrounding the brain. It mostly occurs due to bursts and leaks of a weak area in a blood vessel on the surface of the brain due to which blood builds up around the brain and inside the skull increasing pressure on the brain. The major factor driving the demand for aneurysmal subarachnoid hemorrhage drugs is the increasing geriatric population and the high prevalence of populations suffering from hypertension across the globe.

According to the Center for Disease Control and Prevention, nearly half of adults or 47%, or 116 million have hypertension which is defined as a systolic blood pressure greater than 130 mmHg or diastolic blood pressure greater than 80 mmHg or are taking medication for hypertension in the US. Additionally, about 1 in 4 adults (24%) with hypertension have their condition under control and about half of the adults or 45% or 37 million with uncontrolled hypertension have a blood pressure of 140/90 mmHg or higher in the US. Furthermore, about 34 million adults are recommended to take medication and about two out of three of this group or 19 million have a blood pressure of 140/90 mmHg or higher. Hence, the increasing prevalence of hypertension is creating a risk for aneurysmal subarachnoid hemorrhage which is driving the demand for these drugs.

Some major players in the market include Johnson & Johnson Services, Inc., Pfizer Inc., and Mylan N.V., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market. For instance, in November 2020, Idorsia Ltd. announced positive top-line results of the Japanese registration program which investigated clazosentan in adult Japanese patients post aneurysmal subarachnoid hemorrhage (aSAH).

To Request a Sample of our Report on Aneurysmal Subarachnoid Hemorrhage Drugs Market: https://www.omrglobal.com/request-sample/aneurysmal-subarachnoid-hemorrhage-drugs-market

Market Coverage

The market number available for - 2021-2029
Base year- 2021
Forecast period- 2023-2029
Segment Covered-

By Type
Regions Covered-

North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- Johnson & Johnson Services, Inc., Pfizer Inc., and Mylan N.V., among others.

Aneurysmal Subarachnoid Hemorrhage Drugs Market Report by Segment

By Type

Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic agents/diuretics
Other
A full Report of Aneurysmal Subarachnoid Hemorrhage Drugs Market is Available @ https://www.omrglobal.com/industry-reports/aneurysmal-subarachnoid-hemorrhage-drugs-market

Aneurysmal Subarachnoid Hemorrhage Drugs Market Report by Region

North America

United States
Canada
Europe

UK
Germany
Spain
France
Italy
Rest of Europe
Asia-Pacific

India
China
Japan
South Korea
Rest of APAC
Rest of the World

Latin America
Middle East & Africa
Reasons to buy from us -

We cover more than 15 major industries, further segmented into more than 90 sectors.
More than 120 countries are for analysis.
Over 100+ paid data sources mined for investigation.
Our expert research analysts answer all your questions before and after purchasing your report.

https://www.asiatimeskorea.com/news/2029%eb%85%84%ea%b9%8c%ec%a7%80-%ec%84%b1%ec%9e%a5-%ea%b0%80%ec%86%8d%ed%99%94%eb%a5%bc-%eb%aa%a9%ea%b2%a9%ed%95%98%eb%8a%94-acidophilus-probiotic-%ec%8b%9c%ec%9e%a5/288429/
https://monblogapple.com/2023/01/27/le-marche-des-systemes-de-protection-active-connaitra-une-croissance-fulgurante-dici-2029/
https://citytoday-hildesheim.de/index.php/2023/01/27/der-luftfahrttelekommunikationsmarkt-wird-bis-2029-eine-wachstumsbeschleunigung-erleben/
https://sportmsr.com/%d9%85%d9%86-%d8%a7%d9%84%d9%85%d8%aa%d9%88%d9%82%d8%b9-%d8%a3%d9%86-%d9%8a%d8%b2%d8%af%d8%a7%d8%af-%d8%b3%d9%88%d9%82-%d8%a7%d8%b3%d8%aa%d8%ae%d8%b1%d8%a7%d8%ac-%d8%a7%d9%84%d8%ac%d8%b0%d8%b1-%d9%85/
https://revistaeconomiasocial.com/2023/01/27/el-mercado-de-la-fecula-de-patata-sera-testigo-de-un-crecimiento-asombroso-para-2029/
https://www.diario-ya.com/regionales/%e9%9b%99%e7%9b%b8%e6%83%85%e6%84%9f%e9%9a%9c%e7%a4%99%e8%97%a5%e7%89%a9%e5%b8%82%e5%a0%b4%e5%88%b0-2029-%e5%b9%b4%e5%b0%87%e5%bf%ab%e9%80%9f%e5%a2%9e%e9%95%b7/348282/

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Aneurysmal Subarachnoid Hemorrhage Drugs Market to Witness Robust Expansion by 2029 here

News-ID: 2902690 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Aneurysmal

Aneurysmal Subarachnoid Hemorrhage (aSAH) Market Outlook 2025-2034
Introduction Aneurysmal Subarachnoid Hemorrhage (aSAH) is a life-threatening neurological emergency caused by the rupture of an intracranial aneurysm, leading to bleeding in the subarachnoid space. It accounts for a significant proportion of hemorrhagic strokes and carries high rates of mortality and long-term disability. Prompt diagnosis and treatment are critical for patient survival, driving demand for advanced imaging, neurosurgical devices, and neurocritical care. Growing incidence of hypertension, smoking, alcohol use, and age-related vascular
Aneurysmal Subarachnoid Hemorrhage Market Analysis by Key Players & Industry Siz …
According to a new report published by Allied Market Research, titled, "Aneurysmal Subarachnoid Hemorrhage Market by Therapy Type (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Lumbar Puncture, Xanthochromia, Cerebral Angiography, and Transcranial Doppler Ultrasound) and End User (Hospitals, Clinics, and Other) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The global market size of Aneurysmal Subarachnoid Hemorrhage market is $XX million in 2019 with XX CAGR, and it is expected
Aneurysmal Subarachnoid Hemorrhage Market (2019-2026) Analysis of Top industry S …
According to a new report published by Allied Market Research, titled, "Aneurysmal Subarachnoid Hemorrhage Market by Therapy Type (Computed Tomography (CT) Scan, Magnetic Resonance Imaging (MRI), Lumbar Puncture, Xanthochromia, Cerebral Angiography, and Transcranial Doppler Ultrasound) and End User (Hospitals, Clinics, and Other) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The global market size of Aneurysmal Subarachnoid Hemorrhage market is $XX million in 2019 with XX CAGR, and it is expected
Aneurysmal Subarachnoid Hemorrhage Market Real Time Analysis & Forecast 2017 – …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market - Detailed Study Analysis and Forecast …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the
Aneurysmal Subarachnoid Hemorrhage Market : Manufactures and Key Statistics Anal …
Global Aneurysmal Subarachnoid Hemorrhage Market : Snapshot According to the National Institutes of Health (NIH), aneurysmal subarachnoid hemorrhage (SAH) has turned into a glaring health burden across the world and possesses high rates of permanent disabilities and fatalities. It has been estimated by the NIH that approximately 9 out of 100,000 people across the world suffer from some variation of aneurysmal subarachnoid hemorrhage, a number which is more concerning in the